Neuromodulators for the treatment of headache disorders and fibromyalgia.

Abouch V. Krymchantowski, Juline Bryson, Richard B. Lipton, Marcelo E. Bigal

Research output: Contribution to journalReview article

7 Scopus citations

Abstract

Migraine and fibromyalgia are prevalent and disabling disorders with few preventive medications approved by the US Food and Drug Administration (FDA). Neuromodulators (or antiepileptic drugs; AEDs) are often effective in the treatment of these conditions. Divalproex sodium and topiramate are FDA-approved AEDs for migraine. For fibromyalgia, pregabalin has recently been approved in the United States. We review the use of AEDs in the preventive treatment of these highly prevalent disorders.

Original languageEnglish (US)
Pages (from-to)333-337
Number of pages5
JournalCurrent pain and headache reports
Volume12
Issue number5
DOIs
StatePublished - Oct 2008
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this